Table 5.
Effect of rhEPO on transfusion.
| Indication | Total | Average RBCs transfusion volume (U) | Medication | Non-medication | Z P | |||
|---|---|---|---|---|---|---|---|---|
| cases | Average RBCs transfusion volume (U) | cases | Average RBCs transfusion volume (U) | |||||
| Anemia caused by renal failure | 5,441 | 2.13 ± 0.75 | 1,690 | 1.94 ± 0.55 | 3751 | 2.29 ± 0.79 | −13.93 0.00 | |
| Anemia caused by chemotherapy for non-bone marrow malignant tumors | 7,067 | 2.56 ± 0.97 | 1,140 | 2.41 ± 0.82 | 5927 | 2.68 ± 0.98 | −2.65 0.00 | |
| Perioperative erythrocyte mobilization | 41,408 | 5.46 ± 5.08 | 6,251 | 6.75 ± 6.00 | 35157 | 5.21 ± 4.79 | 25.08 0.00 | |